Brief: Avita Medical Achieves Positive Topline Pivotal Trial Results For Treatment Of Stable Vitiligo Using Recell System
12/09/2022 22:28
Sept 12 (Reuters) - AVITA Medical Inc RCEL.O :
* AVITA MEDICAL ACHIEVES POSITIVE TOPLINE PIVOTAL TRIAL
RESULTS
FOR TREATMENT OF STABLE VITILIGO USING RECELL SYSTEM
* AVITA MEDICAL INC - STUDY ACHIEVED ITS PRIMARY
EFFECTIVENESS
ENDPOINT OF SUPER-SUPERIORITY
* AVITA MEDICAL INC - AVITA MEDICAL CONTINUES TO PLAN FOR
SUBMISSION TO FDA BY END OF 2022
Source text for Eikon: ID:nGNX6w5pMK
Further company coverage: RCEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AVITA Medical
See all newsAvita Medical Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Avita Medical Inc Expected To Post A Loss Of 29 Cents A Share: Earnings Preview
Brief: AVITA Medical Q1 EPS USD -0.35
Brief: AVITA Medical Q4 EPS USD -0.38
Brief: Avita Medical Inc - Enters Into Credit Agreement And Guaranty - SEC Filing